Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity

Novo Nordisk · Phase 1 · Completed · Enrollment 40

NCT04940078

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Part A: Cagrilintide and semaglutide in separate syringesn/rn/rn/rn/r
Part A: Cagrilintide and semaglutide combined in DV3384 devicen/rn/rn/rn/r
Part B: Cagrilintide and semaglutide combined in DV3384 devicen/rn/rn/rn/r

Not shown

  • Part A: Cagrilintide and semaglutide in separate syringes: endpoint not reported
  • Part A: Cagrilintide and semaglutide combined in DV3384 device: endpoint not reported
  • Part B: Cagrilintide and semaglutide combined in DV3384 device: endpoint not reported